https://www.trevena.com/investors/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_94d64ff5c0a1410c39a6df0d6a9dee37/trevena/files/theme/images/logo-sm.png /investors Equisolve Investor Relations Suite https://www.trevena.com/investors/press-releases/detail/346/trevena-reports-third-quarter-2024-results-and-provides-business-update Thu, 07 Nov 24 07:01:00 -0500 https://www.trevena.com/investors/press-releases/detail/346/trevena-reports-third-quarter-2024-results-and-provides-business-update https://www.trevena.com/investors/press-releases/detail/345/trevena-announces-receipt-of-nasdaq-delisting-notification Fri, 04 Oct 24 16:05:00 -0400 https://www.trevena.com/investors/press-releases/detail/345/trevena-announces-receipt-of-nasdaq-delisting-notification https://www.trevena.com/investors/press-releases/detail/344/trevena-announces-reverse-stock-split Thu, 08 Aug 24 16:05:00 -0400 https://www.trevena.com/investors/press-releases/detail/344/trevena-announces-reverse-stock-split https://www.trevena.com/investors/press-releases/detail/343/trevena-reports-second-quarter-2024-results-and-provides-business-update Thu, 08 Aug 24 07:00:00 -0400 https://www.trevena.com/investors/press-releases/detail/343/trevena-reports-second-quarter-2024-results-and-provides-business-update https://www.trevena.com/investors/press-releases/detail/342/trevena-announces-2m-non-dilutive-financing-tranche-and-reduction-in-outstanding-liabilities-in-connection-with-existing-ex-us-royalty-financing Mon, 08 Jul 24 09:15:00 -0400 https://www.trevena.com/investors/press-releases/detail/342/trevena-announces-2m-non-dilutive-financing-tranche-and-reduction-in-outstanding-liabilities-in-connection-with-existing-ex-us-royalty-financing https://www.trevena.com/investors/press-releases/detail/341/trevena-announces-preclinical-trv045-data-providing-insight-into-novel-mechanism-of-analgesic-effect-in-chronic-neuropathic-pain-model-and-demonstrating-statistically-significant-anti-seizure-activity-in-epilepsy-models Thu, 20 Jun 24 07:00:00 -0400 https://www.trevena.com/investors/press-releases/detail/341/trevena-announces-preclinical-trv045-data-providing-insight-into-novel-mechanism-of-analgesic-effect-in-chronic-neuropathic-pain-model-and-demonstrating-statistically-significant-anti-seizure-activity-in-epilepsy-models https://www.trevena.com/investors/press-releases/detail/340/trevena-reports-first-quarter-2024-results-and-provides-business-update Wed, 15 May 24 07:00:00 -0400 https://www.trevena.com/investors/press-releases/detail/340/trevena-reports-first-quarter-2024-results-and-provides-business-update https://www.trevena.com/investors/press-releases/detail/339/trevena-reports-fourth-quarter-2023-results-and-provides-corporate-update Mon, 01 Apr 24 07:00:00 -0400 https://www.trevena.com/investors/press-releases/detail/339/trevena-reports-fourth-quarter-2023-results-and-provides-corporate-update https://www.trevena.com/investors/press-releases/detail/338/trevena-announces-the-closing-of4-million-concurrent-private-placement-and-warrant-exercise Thu, 28 Dec 23 14:00:00 -0500 https://www.trevena.com/investors/press-releases/detail/338/trevena-announces-the-closing-of4-million-concurrent-private-placement-and-warrant-exercise https://www.trevena.com/investors/press-releases/detail/337/trevena-inc-announces-4-million-concurrent-private-placementand-warrant-exercise Wed, 27 Dec 23 09:10:00 -0500 https://www.trevena.com/investors/press-releases/detail/337/trevena-inc-announces-4-million-concurrent-private-placementand-warrant-exercise